Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2025-12-26 @ 9:45 AM
Study NCT ID:
NCT07225504
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-01-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-04
First Submit QC Date:
None
Study First Post Date:
2025-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL